Multi-Omic Profiling of Glioma Patient Tumors and Patient-Derived Model Systems
Demographics (2)
- AGE_SURGERY - Age at time of surgery (phv00529971.v2.p1)
- SEX - Biological sex (phv00529528.v2.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00529972.v2.p1)
Other (20)
- ANALYTE_TYPE - Analyte Type (phv00529533.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00542052.v1.p1)
- CDKN2A_STATUS - Status of CDKN2A genotype determined by whole-exome and RNA sequencing (phv00531391.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00529527.v2.p1)
- FERNANDEZ_2024 - Whether this sample was included in analysis for Fernandez et al. 2024 (phv00542049.v1.p1)
- FERNANDEZ_2024 - Whether this sample was included in analysis for Fernandez et al. 2024 (phv00542056.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00529535.v2.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00542054.v1.p1)
- IS_TUMOR - Tumor status (phv00529534.v1.p1)
- IS_TUMOR - Tumor status (phv00542053.v1.p1)
- MINAMI_2023 - Whether this sample was included in analysis for Minami et al. 2023 (phv00542048.v1.p1)
- MINAMI_2023 - Whether this sample was included in analysis for Minami et al. 2023 (phv00542055.v1.p1)
- SAMPLE_ID - Sample ID (phv00529531.v1.p1)
- SAMPLE_ID - Sample ID (phv00542050.v1.p1)
- SAMPLE_ID - Sample ID (phv00529530.v2.p1)
- SAMPLE_SITE - Body site where sample was collected or type of model system (phv00529532.v1.p1)
- SAMPLE_SITE - Body site where sample was collected or type of model system (phv00542051.v1.p1)
- SUBJECT_ID - Subject ID (phv00529526.v2.p1)
- SUBJECT_ID - Subject ID (phv00529970.v2.p1)
- SUBJECT_ID - Subject ID (phv00529529.v2.p1)